The Basic Principles Of promethazine syrup ip uses in telugu
The Basic Principles Of promethazine syrup ip uses in telugu
Blog Article
इसके साथ अल्कोहल न लें। यह नींद और चक्कर को और बढ़ा सकता है। अपनी और दूसरों की सुरक्षा के लिए, प्रोमेथाज़िन लेने के बाद कोई भी खतरनाक काम न करें।
மருந்தக அளவுக்கான அறிவுறுத்தல்கள் யாவை?
पर्चा अपलोड करके ऑर्डर करें वैध पर्चा कैसा होता है ?
Children. Promethazine/dextromethorphan really should not be used in any child youthful than two years of age. Slow or shallow respiration that may lead to Dying could come about.
உங்களுக்கு சிறுநீர்ப்பை அடைப்பு இருந்தால், இந்த மருந்தை உட்கொள்வது சிறுநீர் கழிப்பதை கடினமாக்கும்.
Stimulation can be apparent, specifically in children and geriatric people. Convulsions may almost never happen. A paradoxical-sort reaction continues to be reported in children receiving one doses of 75 mg to one hundred twenty five mg orally, characterised by hyperexcitability and nightmares.
ஏதேனும் தாய்ப்பாலூட்டுவதற்கான எச்சரிக்கைகள் உள்ளனவா?
Particularly, make absolutely sure that you simply examine If you're using any of the subsequent in advance of using promethazine/phenylephrine.
Breastfeeding. It is far from identified if promethazine/phenylephrine passes into breast milk. Inform your healthcare service provider If you're breastfeeding or want to breastfeed. Your Health care provider will recommend you if you ought to take promethazine/phenylephrine while breastfeeding.
There isn't a common agreement about distinct pharmacological treatment regimens for uncomplicated NMS.
Seizures. Promethazine/phenylephrine may result in seizures, particularly when you have a seizure disorder. You will discover many various types get more info of seizures and some of them are demanding to recognize.
Phenergan Syrup might be safe to use in sufferers with kidney disease. Limited details available indicates that dose adjustment of Phenergan Syrup will not be needed in these people. Please consult your medical doctor.
வலிப்புத்தாக்கங்கள் உள்ளவர்களுக்கு
Phenergan Syrup is most likely Risk-free to implement for the duration of breastfeeding. Limited human data indicates the drug does not represent any sizeable threat on the baby.